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a  b  s  t  r  a  c  t
BACKGROUND:  Familial  adenomatous  polyposis  (FAP)  is  an  autosomal  dominant  cancer  predisposition
syndrome  characterised  by the  progressive  development  of multiple  colorectal  adenomatous  polyps
and  an  increased  incidence  of  colorectal  carcinoma.  It is  often  accompanied  by  other  benign  or  malig-
nant  extracolonic  manifestations,  including  gastric  and  duodenal  tumours,  osteomas,  desmoid  tumours,
retinal pigmentation,  and  thyroid  and  adrenocortical  tumours
METHODS  AND  RESULTS:  We  report  the case  of a 42-year-old  white  female  with  FAP  who  was referred
to  our Endocrine  Surgery  Unit  for surgery  because  of a palpable  mass  in  the  left side  of the  neck.  An
ultrasound-guided  ﬁne  needle  aspiration  biopsy  showed  a cribriform-morular  variant  (CMV)  of papillary
thyroid  carcinoma  (PTC).  The  incidence,  clinical  presentation,  histology  and treatment  options  for  thisribiform
hyroid
rare  histological  subtype  are  discussed.
CONCLUSIONS:  The  diagnosis  of  CMV  of PTC  is  very  strongly  related  to  the  FAP  syndrome  and  must  be
suspected  when  a thyroid  node  appears  in  FAP  patients.  Likewise,  any  patient  without  known  FAP  who
presents  this  histology  in  a surgically  biopsied  or resected  thyroid  node  should  undergo  total  colonoscopy
for  screening  of  colonic  polyposis  and genetic  study  of  the  APC  gene  sequence.
©  2015  The  Authors.  Published  by  Elsevier  Ltd. on behalf  of Surgical  Associates  Ltd.  This  is an  open
he CCaccess  article  under  t
. Introduction
Familial adenomatous polyposis (FAP) is an autosomal dom-
nant cancer predisposition syndrome characterised by the
rogressive development of multiple colorectal adenomatous
olyps and an increased incidence of colorectal carcinoma. It is
ften accompanied by other benign or malignant extracolonic man-
festations, including gastric and duodenal tumours, osteomas,
esmoid tumours, retinal pigmentation, and thyroid and adreno-
ortical tumours [1].
FAP-associated thyroid neoplasms are rare, with a reported inci-
ence of 1–2% in the FAP registries. Most cases of FAP (95–98%)
ffect women younger than 30 years of age with papillary thyroid
arcinoma (PTC). PTC in FAP patients has an increased frequency of
he cribriform-morular variant (CMV), an unusual and peculiar his-
ological subtype with morular areas and a multifocal development
2].We report the case of a patient with a previous diagnosis of
AP who was treated in our Endocrine Surgery Unit for a thyroid
ass. The ﬁnal histological report referred to CMV  of PTC. The inci-
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dence, clinical presentation, histology and treatment options are
also discussed.
2. Case report
A 42-year-old white female with a previous diagnosis of FAP
was referred to our Endocrine Surgery Unit to undergo surgery of
a palpable mass in the left side of the neck. The ultrasound study
revealed a 3.5 cm node in the middle of the left thyroid lobe, with no
evidence of cervical, paratracheal or mediastinal lymphadenopa-
thy. The results of a ﬁne needle aspiration biopsy were consistent
with PTC (Group 5 according to the Bethesda classiﬁcation). In rela-
tion with her FAP, the patient had undergone a subtotal colectomy,
an ampullectomy and resection of a desmoid mesenteric tumour
(10, 5 and 3 years, respectively, before the diagnosis of the thyroid
tumour). The patient’s mother, who had had a nodular goitre, had
died of a digestive tumour and her grandmother of a tumour in the
cervical region of unknown aetiology.
The patient underwent an elective total thyroidectomy with-
out complications. The ﬁnal pathologic diagnosis was a multifocal
bilateral CMV  of PTC, exclusively intrathyroid, with the largest
nodule measuring 3.5 cm.  Figs.1 and 2 show the architectural pat-
tern of papillary and grooved nuclei characteristic of PTC, with
solid zones containing fusiform cells and the cribriform pattern.
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Fig. 1. Architectural pattern of the cribriform-morular variant papillary thyroid car-
cinoma with solid zones containing spindle cells arranged in spiral and grooved



























oig. 2. Microscopic aspect of cribriform lesions of papillary thyroid carcinoma typ-
cally found in familial adenomatous polyposis (Hematoxylin & Eosin; ×150).
he immunohistochemical study revealed TTF1 (+), cytokeratin
+) and beta-catenin (+). Postoperatively, the patient was treated
ith therapeutic radioactive iodine ablation and is currently free
f locoregional recurrence 2 years after surgery.
. Discussion
Many familial syndromes are associated with thyroid neo-
lasms, including Cowden’s disease, Peutz-Jeghers syndrome,
taxia telangiectasia, multiple endocrine neoplasia syndromes and,
ore recently FAP [3]. FAP is a rare condition (1:10000 persons)
ransmitted in an autosomal dominant pattern related to germline
utation of the tumour suppressor gene adenomatous polyposis
oli (APC), which strongly predisposes to colorectal cancer [1]. Thy-
oid carcinoma rarely coexists with FAP (in just 0.3–1.2% of cases),
ut when it does it has a very characteristic and unique micro-
copic pattern, with nearly 100% of cases being CMV  of the papillary
ubtype [4–6]. An exhaustive review of the medical literature has
evealed approximately 200 cases since the ﬁrst description by Crail
n 1949 [7]. Nevertheless, CMV  is only present in 0.1% of patients
ith sporadic PTC.
The diagnosis of CMV  of PTC linked to AFP requires one or more
f the following three features: (a) colonic polyposis detected on
otal colonoscopy before or after thyroid surgery; (b) presence of
PC gene mutations; and, (3) family history of colonic polyposis or
olorectal carcinoma [7]. CMV  of PTC in AFP patients exhibits a typ-
cal epidemiology, with a female:male ratio of 17:1 and a mean age
f 27.65 years. Compared with women without FAP, the risk of CMV
f PTC is 100 times higher, increasing to 160 times higher if onlyPEN  ACCESS
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women under the age of 35 are considered [9,10]. In these circun-
stances, CMV  of PTC can be clearly considered as an extracolonic
manifestation of the FAP syndrome and may  often be present as
early as 4–12 years before colon manifestations.
Macroscopically, CMC  of PTC are typically multifocal and have a
very low potential to disseminate to regional lymph nodes. Ito et al.
compared retrospectively two cohorts of patients with CMV  of PTC,
FAP-associated (n = 19) and sporadic (n = 12), and found that 75% of
the FAP group had multiple tumours on preoperative ultrasound
and 83% had multiplicity on pathological examination (versus 0%
and 11%, respectively, for sporadic cases). All the patients in both
groups were node negative and none had extrathyroid extension
[8]. Iwama and Tomoda reported personal series of 11 and 7 cases,
respectively, with no associated deaths and no cases of recurrence
[11,12]. These ﬁndings explain why  the best surgical treatment
for CMV  of PTC in FAP is total thyroidectomy without the need
for prophylactic central node dissection. Studies have reported 5-
and 20-year survival rates of 90% and 77%, which can be compared
with conventional PTC and suggests an excellent outcome for these
patients if treated appropriately and in a timely fashion with regard
to both thyroid carcinoma and colon cancer [13].
Microscopically, CMV  of PTC presents the distinctive features
of papillary neoplasms with a cribriform and morular architecture.
The concept of “cribriform” explains the perforated architecture,
and “morular” designates the presence of cells in a spindled or
whorled pattern forming nest-like structures, like a morule [14].
Frequently, this pattern may be confused with highly aggressive
neoplasms, but the lack of nuclear atypia, mitosis and necrosis
help in the differential diagnosis. Immunohistochemical studies
describe typical cytoplasmic expression of thyroglobulin, neuron-
speciﬁc enolase, epithelial membrane antigen, low molecular
weight cytokeratin, vimentin and protein bc12. Nuclear expres-
sion of progesterone and oestrogen has also been described. The
expression of retinoblastoma protein and beta-catenin (positive in
our case) in the nucleus and cytoplasm, although less frequent, has
also been reported in some cases [15].
No consensus exists about the need for systematic screening
with cervical ultrasound for thyroid tumours in patients with FAP
because of the low prevalence, but it would not seem to be suf-
ﬁciently cost-effective to justify. Nevertheless, the diagnosis of
a CMV  of PTC in any patient without FAP is highly suggestive
of the familial disease and, accordingly, an indication for total
colonoscopy for screening of colonic polyposis and genetic study
of the APC gene sequence.
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